istock-839222794-nicoelnino-1
NicoElnino / iStockphoto.com
22 November 2018Americas

Leo Pharma and PellePharm sign rare disease deal

Denmark-based Leo Pharma and Californian rare disease company PellePharm have partnered to develop and commercialise therapies for rare forms of skin cancer.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
14 June 2016   Leo Pharma has filed suit against Perrigo in the US District Court for the District of Delaware alleging patent infringement.
Big Pharma
6 October 2014   Drug business Teva invalidated two patents held by Leo Pharma today and will seek to launch a generic version of one of the company’s skin condition treatments.